
4SC-203
CAS No. 895533-09-2
4SC-203( —— )
Catalog No. M28711 CAS No. 895533-09-2
4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 177 | Get Quote |
![]() ![]() |
10MG | 295 | Get Quote |
![]() ![]() |
25MG | 502 | Get Quote |
![]() ![]() |
50MG | 709 | Get Quote |
![]() ![]() |
100MG | 1008 | Get Quote |
![]() ![]() |
500MG | 2007 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Name4SC-203
-
NoteResearch use only, not for human use.
-
Brief Description4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
-
Description4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetFLT
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number895533-09-2
-
Formula Weight1283.53
-
Molecular FormulaC66H74N16O8S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (194.47 mM)
-
SMILESCc(cc1)cc(NC(Nc2nc(ccc(Nc(c3c4)ncnc3cc(OCCCN3CCN(C)CC3)c4OC)c3)c3s2)=O)c1OCCc(cc1)cc(NC(Nc2nc(ccc(Nc(c3c4)ncnc3cc(OCCCN3CCN(C)CC3)c4OC)c3)c3s2)=O)c1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bae Young-Soo, et al. Extractives of the Wood of Black Locust and the Bark of Poplar as Decay-Resistant Hardwood Tree Species. The Journal of veterinary medical science. 2000; 28(3): 52-61.
molnova catalog



related products
-
FLT3-IN-2
FLT3-IN-2 is a FLT3 inhibitor with IC50 of < 1 μM.
-
Pacritinib
Pacritinib (SB1518) is a potent and selective inhibitor of Janus Kinase 2 (JAK2) and Fms-Like Tyrosine Kinase-3 (FLT3) with IC50s of 23 and 22 nM in cell-free assays, respectively. Phase 3.
-
4SC-203
4SC-203 is a multikinase inhibitor with potential antineoplastic activity. 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs).